13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q4 2022. See the latest, Q2 2026 →
Reported value
$498.70B
+6.2% on the quarter before
Positions
1,978
197 new · 238 sold out
Top 10
17.2%
of the value
Est. gain
+$41.11B
on stocks held all quarter
Est. return
+9.6%
on those stocks since Q3 2022
Positions as of Dec 31, 2022, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 31% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2022. Striped tiles are options.
Largest buys
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Merck & Co Inc~$2.43BAdded · 0.7% → 1.4%+21,859,699 shares
- Abbott Labs~$1.44BAdded · 0.0% → 0.3%+13,107,917 shares
- Honeywell Technologies~$1.01BAdded · 0.6% → 0.9%+4,733,461 shares
- Emerson Electric~$756.4MAdded · 0.0% → 0.2%+7,874,249 shares
- American Intl Group Inc~$749.2MAdded · 0.1% → 0.3%+11,846,920 shares
- Eog Res Inc~$748.6MAdded · 0.4% → 0.6%+5,779,996 shares
- Alphabet~$618.5MAdded · 1.3% → 1.3%+7,009,742 shares
- Ross Stores Inc~$524.9MAdded · 0.1% → 0.2%+4,522,607 shares
- Qualcomm~$404.1MAdded · 0.3% → 0.4%+3,675,611 shares
- Schwab Charles Corp~$369.0MAdded · 1.2% → 1.3%+4,431,475 shares
Largest sells
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Bristol-Myers Squibb Co~$1.76BCut · 0.5% → 0.1%−24,466,468 shares
- Tjx Cos Inc New~$1.65BCut · 1.5% → 1.5%−20,671,460 shares
- Baxter Intl Inc~$1.17BCut · 0.7% → 0.4%−22,888,384 shares
- Amazon~$937.1MCut · 1.8% → 1.1%−11,155,584 shares
- Starbucks Corp~$850.0MCut · 0.4% → 0.3%−8,568,423 shares
- Apple~$849.8MCut · 2.0% → 1.6%−6,540,156 shares
- Trane Technologies Plc~$790.4MCut · 0.2% → 0.0%−4,702,196 shares
- Humana Inc~$698.9MCut · 0.9% → 0.8%−1,364,505 shares
- Comcast Corp New~$689.8MCut · 0.4% → 0.3%−19,724,660 shares
- Unitedhealth Group Inc~$675.0MCut · 2.7% → 2.5%−1,273,138 shares
Holdings
As of Dec 31, 2022. Changes are in shares against Sep 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −0.6% · price +3.0% | 3.1% | $15.30B | +$441.5M | ||||||||
| Unitedhealth Group IncCOM · shares −5.0% · price +5.0% | 2.5% | $12.69B | +$601.8M | ||||||||
| Pfizer IncCOM · shares −5.5% · price +17.1% | 2.0% | $10.21B | +$1.49B | ||||||||
| AppleCOM · shares −9.7% · price −6.0% | 1.6% | $7.88B | −$501.7M | ||||||||
| Tjx Cos Inc NewCOM · shares −18% · price +28.1% | 1.5% | $7.34B | +$1.61B | ||||||||
| Eli LillyCOM · shares −8.4% · price +13.1% | 1.5% | $7.32B | +$850.2M | ||||||||
| Merck & Co IncCOM · shares +54% · price +28.8% | 1.4% | $6.88B | +$997.1M | ||||||||
| Schwab Charles CorpCOM · shares +5.9% · price +15.8% | 1.3% | $6.65B | +$859.0M | ||||||||
| AlphabetCAP STK CL A · shares +11% · price −7.8% | 1.3% | $6.31B | −$478.7M | ||||||||
| Jpmorgan Chase & CoCOM · shares +5.1% · price +28.3% | 1.1% | $5.37B | +$1.13B | ||||||||
| Danaher CorporationCOM · shares +5.9% · price +2.8% | 1.1% | $5.33B | +$135.2M | ||||||||
| AmazonCOM · shares −15% · price −25.7% | 1.1% | $5.25B | −$1.81B | ||||||||
| MastercardCL A · shares −4.2% · price +22.3% | 1.0% | $5.19B | +$946.9M | ||||||||
| ConocophillipsCOM · shares +1.4% · price +15.3% | 1.0% | $5.14B | +$672.9M | ||||||||
| Procter And Gamble CoCOM · shares −9.6% · price +20.0% | 1.0% | $5.04B | +$841.0M | ||||||||
| Visa Inc.COM CL A · shares −2.7% · price +16.9% | 0.96% | $4.77B | +$690.9M | ||||||||
| Johnson & JohnsonCOM · shares −4.0% · price +8.1% | 0.95% | $4.75B | +$357.0M | ||||||||
| Home Depot IncCOM · shares +0.2% · price +14.5% | 0.94% | $4.67B | +$589.3M | ||||||||
| Honeywell TechnologiesCOM · shares +28% · price +28.3% | 0.93% | $4.62B | +$797.3M | ||||||||
| Elevance Health IncCOM · shares −4.6% · price +12.9% | 0.90% | $4.50B | +$515.8M | ||||||||
| Texas InstrumentsCOM · shares −11% · price +6.7% | 0.90% | $4.48B | +$283.0M | ||||||||
| Chubb LimitedCOM · shares −6.0% · price +21.3% | 0.87% | $4.35B | +$763.3M | ||||||||
| Raytheon Technologies CorpCOM · shares −2.9% · price +23.3% | 0.86% | $4.27B | +$806.8M | ||||||||
| Mcdonalds CorpCOM · shares −7.1% · price +14.2% | 0.85% | $4.24B | +$527.5M | ||||||||
| Exelon CorporationCOM · shares +5.9% · price +15.4% | 0.84% | $4.16B | +$524.7M | ||||||||
| Total · 1,978 positions | 100% | $498.70B | +$41.11B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2022 to Q4 2022: 1,693 stocks held throughout, up $41.11B (+9.6%).
- Tjx Cos Inc New+$1.61B+28%
- Pfizer Inc+$1.49B+17%
- Jpmorgan Chase & Co+$1.13B+28%
- Nike Inc+$1.11B+41%
- Merck & Co Inc+$997.1M+29%
- M & T Bk Corp−$321.5M−18%
- Alphabet−$478.7M−8%
- Apple−$501.7M−6%
- Tesla−$524.3M−54%
- Amazon−$1.81B−26%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |